Industrial Pharmacy Practice Notes-1
Industrial Pharmacy Practice Notes-1
Industrial Pharmacy Practice Notes-1
Relevant legislation
Licensing of Products
- This is to be down for products to be used in the Kenyan
market
- A separate application must be made for each product
that differs in strength, form, API. One application can
be given for the same product but different pack size.
- A summary of recommendations of evaluation, lab
analysis and GMP status reports will be presented to a
Committee of Drug registration for consideration and
they reject or approve the product.
- If the board approves according to cap 244, a marketing
authorisation will be given.
- Pharmaceutical products that are registered are valid
for 5 years, unless suspended or revoked
Pharmaceutical Marketing
- Any advertisement being made for a pharmaceutical
product must have clearing and authorisation by the
PPB
- The adverts must not be misleading, claim to be better
than another, not show children using the medication,
unbiased, endorse KMA, PSK etc., no offers and samples
should be given
- An advertisement should not refer to an Act or any
department or official of the Board
- Any medication for the following cannot be advertised:
1. Cure of amenorrhea, STIs, HIV/AIDs
2. The cure of any habit associated with sexual
indulgence or ailments associated with this, or the
restoration or stimulation of the sexual functions
3. The prevention, relief or cure of blindness, bright’s
disease, schistosomiasis, cancer and malignancies
4. The cure of alcoholism, appendicitis,
arteriosclerosis, bladder stones, cardiovascular
disease, cataract, diabetes, diphtheria, dropsy,
epilepsy, gallstones, gangrene, glaucoma, goitre,
heart disease hernia, hyper/hypotension, infantile
diarrhoea, kidney stone, leprosy, ataxia, lupus,
meningitis, MS, osteoarthritis, Parkinson’s, polio,
pneumonia, RA, tetanus, TB
5. Use of medicines to add or lose weight or alter
bodily functions apart from those scientifically
proven.